R. Gurion

A 4‐Year‐Old Amish Boy With Weakness, Arthritis, Rash, Verbal Delay, and Failure to Thrive

M. Wiznitzer, A. Mitchell, Elizabeth B Brooks, 2013, Arthritis care & research.

Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy

E. Yow, G. McComsey, L. Schanberg, 2014, Lupus Science & Medicine.

Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature

E. Yow, G. McComsey, L. Schanberg, 2015, Pediatric Rheumatology.

Index of Suspicion in the NurseryCase 1: Enlarged Heart in a Term InfantCase 2: Widespread Rash in an InfantCase 3: Apnea and Cyanosis in a 3-week-old Infant

M. Trautman, P. Faught, L. Moorthy, 2011 .

Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding.

M. Masterson, A. Siu, A. Weiss, 2012, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

Systemic Arthritis in Children: A Review of Clinical Presentation and Treatment

T. Lehman, L. Moorthy, R. Gurion, 2011, International journal of inflammation.

Tocilizumab in Pediatric Rheumatology: The Clinical Experience

N. Singer, R. Gurion, 2013, Current Rheumatology Reports.

Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy

E. Yow, G. McComsey, L. Schanberg, 2014, Lupus Science & Medicine.

Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy

E. Yow, G. McComsey, L. Schanberg, 2014, Lupus Science and Medicine.